AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
NATALIZUMAB in Tunisia
1 product registered with DPM — 0 active, 1 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| TYSABRI 300 MG Solution injectable pour perfusion / 20 mg/ml | 10913041H | BIOGEN Idec Ltd | expired | 8 Oct 2020 |
NATALIZUMAB — DPM Registration Details
DPM (Tunisia) has 1 registered product containing NATALIZUMAB, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track NATALIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.